Watch: the CureRays® explainer series
Prefer to read? The full guide below is complete on its own, with tables you can revisit any time.
What is meningioma (brain & spine membrane tumor)?
A meningioma is a tumor that grows from the meninges, the thin protective membranes that wrap around the brain and spinal cord. It is the most common primary tumor of the central nervous system, and the large majority are benign (non-cancerous), slow-growing, and well-behaved. Because a meningioma arises from the covering rather than from the brain itself, it tends to push on the brain or spinal cord from the outside rather than invading through it, which is part of why so many can be controlled or even cured. Many meningiomas are found by chance on a scan done for another reason and never cause any symptoms. When they do cause problems, it is usually because of where they sit and what they press on: headaches, seizures, weakness, vision or hearing changes, or — for ones along the spine — back pain, numbness, or weakness in the limbs. They are more common in women and become more common with age. The behavior of a meningioma depends heavily on its grade. Most are grade 1 (benign and slow). A smaller number are grade 2 (atypical), which are more likely to come back, and a few are grade 3 (malignant/anaplastic), which behave aggressively. Because most meningiomas grow slowly and many never cause trouble, a common and appropriate first step — especially for small, symptom-free tumors found incidentally — is careful monitoring with periodic scans. When treatment is needed, the main tools are surgery and radiation, and these are often complementary: surgery removes what it safely can, and precise radiation controls what remains or treats tumors in locations too risky to operate on.
The main types
Doctors group meningioma (brain & spine membrane tumor) by where it starts and how it behaves:
| Type | What it means, simply |
|---|---|
| Grade 1 (benign) meningioma | By far the most common type — slow-growing and non-cancerous; many are watched, and those needing treatment are often cured by surgery or controlled long-term by focused radiation. |
| Grade 2 (atypical) meningioma | A more active tumor with a higher tendency to come back after removal; treatment often combines surgery with radiation to lower the chance of recurrence. |
| Grade 3 (anaplastic/malignant) meningioma | An uncommon, aggressive form that grows quickly and frequently recurs; treated with surgery and radiation, and managed closely over time. |
| Skull-base and spinal meningiomas | Tumors in difficult locations — at the base of the skull near nerves and blood vessels, or along the spinal cord — where complete surgery is risky, making precise radiation a key option. |
Staging, in plain terms
Meningiomas are not staged with the TNM system used for cancers that spread through the body, because they almost always stay in one place and rarely travel elsewhere. Instead, what matters most is the grade, assigned by examining the tumor under a microscope and graded by the World Health Organization (WHO) from 1 to 3. Grade 1 tumors are benign and slow; grade 2 (atypical) are intermediate and more likely to return; grade 3 (anaplastic) are malignant and aggressive. The second key factor is how completely the tumor can be removed by surgery, described by a scale (the Simpson grade) that records whether the tumor and its attachment to the meninges were fully taken out — more complete removal means a lower chance of recurrence. Location is the third major factor: a tumor sitting over the surface of the brain may be straightforward to remove, while one wrapped around critical nerves, blood vessels, or the brainstem at the skull base may be impossible to remove completely without harm, which is exactly where radiation becomes essential. Size, growth rate on serial scans, and whether the tumor is causing symptoms round out the picture. Together, grade, extent of removal, and location guide whether a meningioma is simply watched, removed, irradiated, or treated with a combination.
| No TNM staging — meningiomas are classified by WHO grade (1–3) and by how completely they can be removed | What it generally means |
|---|---|
| Incidental, small, symptom-free | A small meningioma found by chance with no symptoms; usually managed with active surveillance — periodic MRI scans — since many never grow enough to need treatment. |
| Grade 1, treatment needed | A benign meningioma that is growing or causing symptoms; treated with surgery when accessible, or with focused radiation (including single-session radiosurgery) for tumors in risky locations, with excellent long-term control. |
| Grade 2 (atypical) | A more recurrence-prone tumor; usually treated with surgery followed by radiation, especially if removal was incomplete, to reduce the chance it returns. |
| Grade 3 (anaplastic/malignant) | An aggressive meningioma; treated with maximal safe surgery and radiation, with close ongoing monitoring and consideration of clinical trials. |
The standard of care
Meningioma (Brain & Spine Membrane Tumor) is almost always treated by a team that may include a surgeon, a medical oncologist, and a radiation oncologist, combining therapies for the best result. The usual building blocks are:
Active surveillance
For small, symptom-free meningiomas found incidentally, periodic MRI monitoring is often the wisest first step, since many never grow enough to need any treatment.
Surgery
Removing the tumor relieves pressure, provides a diagnosis and grade, and can cure benign meningiomas when complete removal is safely possible.
Stereotactic radiosurgery (SRS)
A highly focused, often single-session dose of radiation that controls small to moderate meningiomas — including those in locations too risky to operate on — while sparing surrounding brain.
Fractionated radiation therapy
Radiation given as several smaller daily treatments for larger tumors or those near sensitive structures like the optic nerves; used as primary treatment or after surgery for higher-grade or incompletely removed tumors.
Treatment for recurrent or aggressive disease
For tumors that come back or are higher grade, repeat surgery, repeat or additional radiation, and enrollment in clinical trials of newer therapies are considered.
How radiation treatment works
Radiation therapy controls a meningioma by delivering precisely targeted energy that damages the DNA inside the tumor cells, so they lose the ability to grow and divide. Because most meningiomas grow slowly, the goal of radiation is usually long-term control — stopping the tumor from enlarging and, over time, often shrinking it — rather than a sudden disappearance. The defining feature of modern radiation for meningiomas is precision. In stereotactic radiosurgery, many beams are aimed from different directions so they all cross at the tumor; each beam alone is gentle, but together they deliver a strong dose right at the target, and the dose drops off so sharply at the edges that the surrounding brain receives very little. This allows a meningioma to be treated in a single session or a few sessions, often without an incision, which is why radiosurgery is so valuable for tumors at the skull base — wrapped around nerves, blood vessels, or the brainstem — where surgery would be dangerous. For larger tumors, or ones sitting right against a sensitive structure like the optic nerve, the dose is instead divided into several smaller daily treatments (fractionated radiotherapy), which lets those delicate tissues recover between sessions while still controlling the tumor. Radiation is used in several ways: as the primary treatment for tumors that cannot be safely removed, as an addition after surgery for higher-grade tumors or when removal was incomplete, and to treat tumors that come back. Long-term control rates for benign meningiomas treated with focused radiation are very high — often well above 90% at ten years — and because the surrounding brain is protected, most people keep their neurological function. Proton therapy, where available, can further reduce dose to healthy tissue beyond the tumor, an advantage for large skull-base tumors and younger patients.
The main ways radiation is delivered for meningioma (brain & spine membrane tumor):
Stereotactic radiosurgery (SRS)
Many precisely aimed beams converge on the tumor to deliver a high dose in a single session (or a few sessions), with the dose falling off sharply at the edges so the surrounding brain is largely spared — ideal for small-to-moderate and skull-base meningiomas.
Fractionated stereotactic radiotherapy (FSRT)
The same precise targeting delivered as several smaller daily treatments, preferred when a tumor is larger or sits right next to a sensitive structure such as the optic nerve, allowing those tissues to tolerate the treatment safely.
Postoperative (adjuvant) radiation
After surgery for a grade 2 or 3 tumor, or when a benign tumor could not be fully removed, radiation to the tumor bed lowers the chance the meningioma returns.
Proton therapy in selected cases
Proton beams deposit their dose and then stop, reducing radiation to healthy brain beyond the target — valuable for larger skull-base tumors and for younger patients where limiting lifetime exposure matters.
Latest studies shaping care
Care keeps improving — often toward getting the same excellent results with less burden on patients. A few developments:
Radiosurgery achieves durable long-term control of benign meningiomas: Large long-term series of stereotactic radiosurgery for grade 1 meningiomas report tumor control rates above 90% at ten years with low rates of serious side effects, supporting radiosurgery as a primary option for small-to-moderate and skull-base tumors.[1]
Long-term meningioma radiosurgery cohorts
Postoperative radiation reduces recurrence in atypical (grade 2) meningiomas: Clinical trials and large analyses indicate that radiation after surgery improves control of grade 2 meningiomas, with ongoing studies refining exactly which patients benefit most after a complete versus incomplete removal.[2]
Atypical meningioma adjuvant radiation trials
Molecular profiling refines meningioma treatment: Newer analysis of the genetic and molecular features of meningiomas predicts which tumors are likely to recur better than grade alone, helping tailor decisions about surgery, radiation timing, and surveillance.[3]
Meningioma molecular classification research
Common questions
My scan found a meningioma but I feel fine — do I need treatment? Often not right away. Many meningiomas are found by chance, are small, and grow very slowly, so a common and appropriate first step is active surveillance — periodic MRI scans to see whether it changes. Treatment is recommended if the tumor grows or starts to cause symptoms. Watching it closely avoids the risks of treatment for a tumor that may never need any.
What is radiosurgery, and is it actually surgery? Despite the name, stereotactic radiosurgery involves no cutting. It uses many precisely aimed radiation beams that converge on the tumor to deliver a strong dose in a single session (or a few), while sparing the surrounding brain. It is especially useful for small-to-moderate meningiomas and for tumors at the skull base that would be dangerous to remove with an operation.
Will radiation harm my brain? Modern focused radiation is designed to protect the healthy brain. The dose is concentrated on the tumor and falls off sharply at the edges, and when a tumor is larger or near a sensitive area like the optic nerve, the treatment is divided into several smaller sessions so those tissues tolerate it well. Most people keep their neurological function, and serious side effects are uncommon.
References
Numbered sources for the studies cited above. Links open the primary publication on PubMed or the publisher’s site.